文献速递前列腺癌

局限性前列腺癌近距离放疗后的睾酮水平变化

Testosterone Profiles After Brachytherapy for Localized Prostate Cancer.
PubMed 文献 · Urology · 2019-02-01

本研究纳入102例接受碘-125永久性间质近距离放疗(剂量145 Gy)且未行雄激素剥夺治疗的局限性前列腺癌患者,随访24-60个月。放疗后总睾酮显著下降,中位最低值为基线的89.4%(3.72 ng/mL),6个月时出现,18个月恢复至基线。

要点

  • 碘-125近距离放疗后总睾酮显著下降,中位最低值为基线的89.4%(3.72 ng/mL),6个月时出现并在18个月恢复至基线。
  • 放疗后睾酮降至3.00 ng/mL以下(生化性性腺功能减退)组基线中位睾酮为3.54 ng/mL,未降至3.00 ng/mL以下组为4.90 ng/mL。
  • 研究期间睾酮下降超过1.00 ng/mL组基线中位睾酮为5.05 ng/mL,下降小于1.00 ng/mL组为3.64 ng/mL。

核心结论

  • 碘-125近距离放疗后总睾酮显著下降,但降幅不大且随时间恢复。

研究设计与样本

  • 纳入102例接受碘-125永久性间质近距离放疗(剂量145 Gy)且未行雄激素剥夺治疗的局限性前列腺癌患者,随访24-60个月。

主要发现

  • 放疗前中位总睾酮为4.18 ng/mL,放疗后显著下降至中位最低值3.72 ng/mL(基线的89.4%),出现在6个月时,18个月恢复至基线。
  • 放疗后总睾酮降至3.00 ng/mL以下(生化性性腺功能减退)组基线中位总睾酮为3.54 ng/mL,未降至3.00 ng/mL以下组为4.90 ng/mL。
  • 研究期间总睾酮下降超过1.00 ng/mL组基线中位总睾酮为5.05 ng/mL,下降小于1.00 ng/mL组为3.64 ng/mL。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: To evaluate patients' serum total testosterone levels (STLs) after brachytherapy (BT) for prostate cancer. METHODS: We enrolled 102 men who underwent permanent interstitial BT using I125 without androgen deprivation therapy for localized prostate cancer. Seed BT radiation dose was 145 Gy. Patients were followed for 24-60 months after BT. The primary outcome was STL kinetics after BT. Predictors of testosterone decrease were also analyzed. RESULTS: Median preimplantation STL was 4.18 ng/mL. STL decreased significantly to a median nadir of 89.4% of baseline (3.72 ng/mL) occurring at 6 months, and then recovered to baseline at 18 months after BT. The group of patients whose STLs fell below 3.00 ng/mL (biochemical hypogonadism) after BT started with lower baseline STLs (median: 3.54 ng/mL) than patients whose STLs did not fall below 3.00 ng/mL (median: 4.90 ng/mL). The group of patients whose STLs decreased by more than 1.00 ng/mL over the study period had significantly higher median baseline STLs (median: 5.05 ng/mL) than the group whose STLs decreased by less than 1.00 ng/mL (median: 3.64 ng/mL). CONCLUSION: Although STL decreased significantly after I125-based BT, STL decline after treatment for localized prostate cancer was not large and recovered over time.

来源:Urology,查看原文。版权归原作者所有。

引用

  1. Taniguchi H, Kawakita S, Kinoshita H, et al. Testosterone Profiles After Brachytherapy for Localized Prostate Cancer. Urology. 2019. PMID: 30716344. doi:10.1016/j.urology.2019.01.022

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。